A detailed history of Barr E S & CO transactions in Amgen Inc stock. As of the latest transaction made, Barr E S & CO holds 905 shares of AMGN stock, worth $309,247. This represents 0.01% of its overall portfolio holdings.

Number of Shares
905
Previous 957 5.43%
Holding current value
$309,247
Previous $267,000 4.49%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$271.18 - $309.22 $14,101 - $16,079
-52 Reduced 5.43%
905 $255,000
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $209,248 - $259,787
957 New
957 $257,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Barr E S & CO Portfolio

Follow Barr E S & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barr E S & CO, based on Form 13F filings with the SEC.

News

Stay updated on Barr E S & CO with notifications on news.